| Sign In to gain access to subscriptions and/or personal tools. |
Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the diseaseSection of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy
Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy
Section of Neurology, Department of Medical and Surgical Disciplines, University of Ferrara, Italy
Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy
Section of Neurology, Department of Medical and Surgical Disciplines, University of Ferrara, Italy
Section of Neurology, Department of Medical and Surgical Disciplines, University of Ferrara, Italy
Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy, dil{at}dns.unife.it
Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Italy The presence and the replicative state of human herpesvirus 6 (HHV-6) were evaluated in clinical samples from multiple sclerosis (MS) patients at the first time of MS diagnosis. HHV-6 variant B was present in peripheral blood mononuclear cells of 5/32 (15%) patients, but persisted with a latent infection. Viral sequences were present also in cerebrospinal fluid (CSF), both free in the liquid (7/32, 22%) and latent in the cellular fraction (3/32, 9%), as shown by analysis of viral transcription. In these cases, variant A was detected. HHV-6 DNA sequences present in the CSF were associated to mature viral particles. In fact, in vitro infectious assays of CSF showed the presence of replication-competent virions. These results show that about 20% of MS patients have active foci of HHV-6 variant A infection in the early stages of the disease and suggest that viral replication takes place within the central nervous system.
Key Words: ELISA human herpesvirus 6 multiple sclerosis transcription viral infection viral latency
Multiple Sclerosis, Vol. 10, No. 4,
348-354 (2004) This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




